Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Senn

Showing results (61-70 of 193) with videos related to

Pageof 20
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1992
Plicamycin and pamidronate in symptomatic tumor-related hypercalcemia: a prospective randomized crossover trialB Thürlimann, R Waldburger, H J Senn, et al.
The Journal of Rheumatology|January 1, 1988
Allopurinol hypersensitivity in a patient with coexistent systemic lupus erythematosus and tophaceous goutJ McDonald, A G Fam, T Paton, et al.
Schweizerische Medizinische Wochenschrift|November 12, 1977
[Osteomyelofibrosis syndrome 33 years after thorotrast angiography]A Giger, G Meuret, U Schmid, et al.
The Oncologist|February 1, 2021
Implementing Historical Controls in Oncology TrialsOlivier Collignon, Anna Schritz, Riccardo Spezia, et al.
Biochemical Pharmacology|June 1, 1988
SCH 28080 is a lumenally acting, K+-site inhibitor of the gastric (H+ + K+)-ATPaseD J Keeling, S M Laing, J Senn-Bilfinger
Schweizerische Medizinische Wochenschrift|December 9, 1978
[Curability of advanced malignant lymphoma under conditions of modern combination chemotherapy]A F Viollier, H J Senn, J P Obrecht
Deutsche Medizinische Wochenschrift (1946)|December 2, 1983
[Chemotherapy of metastasizing breast cancer. Adriamycin mono and combination therapy after LMFP pretreatment]P J Waibel, W F Jungi, H J Senn
Schweizerische Medizinische Wochenschrift|July 9, 1991
[Why do cancer patients use alternative medicine?]R Morant, W F Jungi, C Koehli, et al.
Acta Haematologica|January 1, 1976
Intravascular fate of granulocytes administered by granujlocyte transfusionsG Meuret, H J Senn, V De Fliedner, et al.
Arzneimittel-Forschung|November 1, 1989
Suitability of long-acting metoclopramide for prophylaxis of chemotherapy-induced delayed nausea and vomitingC Wilder-Smith, J Schimke, H Vergin, et al.
Pageof 20

Showing results (61-70 of 193) with videos related to

Sort By:
Pageof 20
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1992
Plicamycin and pamidronate in symptomatic tumor-related hypercalcemia: a prospective randomized crossover trialB Thürlimann, R Waldburger, H J Senn, et al.
The Journal of Rheumatology|January 1, 1988
Allopurinol hypersensitivity in a patient with coexistent systemic lupus erythematosus and tophaceous goutJ McDonald, A G Fam, T Paton, et al.
Schweizerische Medizinische Wochenschrift|November 12, 1977
[Osteomyelofibrosis syndrome 33 years after thorotrast angiography]A Giger, G Meuret, U Schmid, et al.
The Oncologist|February 1, 2021
Implementing Historical Controls in Oncology TrialsOlivier Collignon, Anna Schritz, Riccardo Spezia, et al.
Biochemical Pharmacology|June 1, 1988
SCH 28080 is a lumenally acting, K+-site inhibitor of the gastric (H+ + K+)-ATPaseD J Keeling, S M Laing, J Senn-Bilfinger
Schweizerische Medizinische Wochenschrift|December 9, 1978
[Curability of advanced malignant lymphoma under conditions of modern combination chemotherapy]A F Viollier, H J Senn, J P Obrecht
Deutsche Medizinische Wochenschrift (1946)|December 2, 1983
[Chemotherapy of metastasizing breast cancer. Adriamycin mono and combination therapy after LMFP pretreatment]P J Waibel, W F Jungi, H J Senn
Schweizerische Medizinische Wochenschrift|July 9, 1991
[Why do cancer patients use alternative medicine?]R Morant, W F Jungi, C Koehli, et al.
Acta Haematologica|January 1, 1976
Intravascular fate of granulocytes administered by granujlocyte transfusionsG Meuret, H J Senn, V De Fliedner, et al.
Arzneimittel-Forschung|November 1, 1989
Suitability of long-acting metoclopramide for prophylaxis of chemotherapy-induced delayed nausea and vomitingC Wilder-Smith, J Schimke, H Vergin, et al.
Pageof 20